Suchergebnisse - "Sharma, Puza P"

PubPharm (83)

1

1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure

enthalten in: Inflammatory bowel diseases | 2024

von Dalal, R. | Sharma, P. | Bains, K. | +2

2

Experience with Tofacitinib in Patients with Ulcerative Colitis : Data from a United States Claims Database

enthalten in: Digestive diseases and sciences | 2023

von Chiorean, M. | Ha, C. | Hur, P. | +3

3

Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort

enthalten in: Inflammatory bowel diseases | 2023

von Dalal, R. | Sharma, P. | Bains, K. | +2

CommentIn: Inflamm Bowel Dis. 2023 Dec 24;:. - PMID 38142413

4

Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database

enthalten in: Digestive diseases and sciences | 2023

von Chiorean, M. | Ha, C. | Hur, P. | +3

5

1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure : A Real-World Cohort Study in the United States

enthalten in: Inflammatory bowel diseases | 2023

von Dalal, R. | Sharma, P. | Bains, K. | +2

6

Tofacitinib Response in Ulcerative Colitis (TOUR) : Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting

enthalten in: Inflammatory bowel diseases | 2023

von Long, M. | Afzali, A. | Fischer, M. | +16

7

Correction to : Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

enthalten in: BMC gastroenterology | 2022

von Chiorean, M. | Allegretti, J. | Sharma, P. | +7

ErratumFor: BMC Gastroenterol. 2022 Apr 9;22(1):177. - PMID 35397501

8

Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

enthalten in: BMC gastroenterology | 2022

von Chiorean, M. | Allegretti, J. | Sharma, P. | +7

9

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

enthalten in: BMC gastroenterology | 2022

von Chiorean, M. | Allegretti, J. | Sharma, P. | +7

ErratumIn: BMC Gastroenterol. 2022 Jul 26;22(1):356. - PMID 35883049

10

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

enthalten in: BMC gastroenterology | 2022

von Chiorean, M. | Allegretti, J. | Sharma, P. | +7

1
2
3
4
5
6
7
8
9
Nächster »
[9]